Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance
NCT02969200
·
clinicaltrials.gov ↗
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class
Conditions
Fabry Disease
Interventions
DRUG:
Enzyme replacement therapy
Sponsor
Ulla Feldt-Rasmussen